Lv1
10 积分 2025-08-05 加入
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
8天前
已完结
D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC
11天前
已完结
Inhibition of Xenograft Tumor Growth and Down-Regulation of ErbB Receptors by an Antibody Directed against Lewis Y Antigen
1个月前
已完结
Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy
1个月前
已完结
Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment
1个月前
已完结
Integrated Two-Analyte Population Pharmacokinetics Model of Patritumab Deruxtecan (HER3-DXd) Monotherapy in Patients with Solid Tumors
1个月前
已完结
In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin
1个月前
已关闭
An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy
1个月前
已完结
Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling
1个月前
已完结
Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study
2个月前
已完结
皖公网安备34019202002308
